Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial

Author:

Lam Phillip H.12,Dooley Daniel J.12,Fonarow Gregg C.3,Butler Javed4,Bhatt Deepak L.5,Filippatos Gerasimos S.6,Deedwania Prakash7,Forman Daniel E.8,White Michel9,Fletcher Ross D.110,Arundel Cherinne111,Blackman Marc R.11011,Adamopoulos Chris12,Kanonidis Ioannis E.13,Aban Inmaculada B.14,Patel Kanan15,Aronow Wilbert S.16,Allman Richard M.17,Anker Stefan D.1819,Pitt Bertram20,Ahmed Ali11114

Affiliation:

1. Veterans Affairs Medical Center; Washington DC USA

2. Georgetown University/MedStar Washington Hospital Center; Washington DC USA

3. University of California; Los Angeles CA USA

4. Stony Brook University; Stony Brook NY USA

5. Brigham and Women's Hospital Heart and Vascular Center; Boston MA USA

6. Attikon University Hospital; Athens Greece

7. University of California; San Francisco, Fresno CA USA

8. University of Pittsburgh and VA Pittsburgh Healthcare System; Pittsburgh PA USA

9. Université de Montréal; Montreal Canada

10. Georgetown University; Washington DC USA

11. George Washington University; Washington DC USA

12. St Paul General Hospital; Thessaloniki Greece

13. Hippocration Hospital; Thessaloniki Greece

14. University of Alabama at Birmingham; Birmingham AL USA

15. University of California; San Francisco CA USA

16. Westchester Medical Center and New York Medical College; Valhalla NY USA

17. Department of Veterans Affairs; Geriatrics and Extended Care; Washington DC USA

18. Division of Cardiology and Metabolism - Heart Failure, Cachexia and Sarcopenia, Department of Cardiology (CVK); and Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Berlin; Charité Universitätsmedizin Berlin; Germany

19. Department of Cardiology and Pneumology; University Medicine Göttingen; Germany

20. University of Michigan; Ann Arbor MI USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3